Zhu Lin, Lian Wanyi, Yao Zhiwen, Yang Xiao, Wang Ziyi, Lai Yupei, Xu Shiting, Zhao Bingcheng, Liu Kexuan
Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
J Inflamm Res. 2022 Apr 14;15:2397-2411. doi: 10.2147/JIR.S351990. eCollection 2022.
Intestinal ischemia/reperfusion (I/R) injury is an unresolved clinical challenge due to its high prevalence, difficulty in diagnosis, and lack of clinically effective therapeutic agents. Ferroptosis is a novel form of cell-regulated death that has been shown to play a role in various I/R models and has been shown to be immune-related. Further unraveling the molecular mechanisms associated with ferroptosis and immunity in intestinal I/R injury may lead to the discovery of potentially effective drugs.
We obtained differentially expressed mRNAs (DEGs) in mouse intestinal tissues following intestinal I/R injury or sham surgery. Then, we extracted ferroptosis-related DEGs (FRGs) and immune-related DEGs (IRGs) from the DEGs. In addition, we performed functional analysis of FRGs and IRGs. Next, we used transcriptome sequencing from patients with intestinal I/R injury to validate the results. Then, we constructed transcription factors (TFs)-gene networks and gene-drug networks using mouse and human co-expressed FRGs (coFRG) and mouse and human co-expressed IRGs (coIRG). We also analyzed the composition of immune cells to reveal correlations between FRGs signatures and immune cells in the mouse and human gut. Finally, we validated these results through animal experiments.
We extracted 61 FRGs and 294 IRGs from mouse samples and performed PPI and functional analyses. We extracted 45 FRGs and 200 IRGs from human samples for validation, and identified 24 coFRGs,100 coIRGs and 6 hub genes (HSPA5, GDF15, TNFAIP3, HMOX1, CXCL2 and IL6) in both. We also predicted potential TF-gene networks for coFRGs and coIRGs, as well as predicted gene-drug pairs for hub genes. In addition, we found that the immune cells were altered in the early stages of intestinal I/R injury and that FRGs were closely associated with immune cells in mice and humans. Finally, we validated the hub genes in mouse samples.
In conclusion, we identified ferroptosis and immunity-related genes to predict their correlations in intestinal I/R injury. We also predicated potential TF-genes network and potential therapeutic targets (HSPA5, GDF15, TNFAIP3, HMOX1, CXCL2 and IL6) to provide clues for further investigation of intestinal I/R injury.
肠缺血/再灌注(I/R)损伤因其高发病率、诊断困难以及缺乏临床有效的治疗药物,仍是一个尚未解决的临床挑战。铁死亡是一种新的细胞调节性死亡形式,已被证明在各种I/R模型中起作用,并且与免疫相关。进一步阐明肠I/R损伤中与铁死亡和免疫相关的分子机制可能会发现潜在的有效药物。
我们获取了小鼠肠I/R损伤或假手术后肠组织中差异表达的mRNA(DEG)。然后,我们从这些DEG中提取了铁死亡相关的DEG(FRG)和免疫相关的DEG(IRG)。此外,我们对FRG和IRG进行了功能分析。接下来,我们使用肠I/R损伤患者的转录组测序来验证结果。然后,我们使用小鼠和人类共表达的FRG(coFRG)以及小鼠和人类共表达的IRG(coIRG)构建转录因子(TF)-基因网络和基因-药物网络。我们还分析了免疫细胞的组成,以揭示小鼠和人类肠道中FRG特征与免疫细胞之间的相关性。最后,我们通过动物实验验证了这些结果。
我们从小鼠样本中提取了61个FRG和294个IRG,并进行了蛋白质-蛋白质相互作用(PPI)和功能分析。我们从人类样本中提取了45个FRG和200个IRG进行验证,并在两者中鉴定出24个coFRG、100个coIRG和6个枢纽基因(热休克蛋白家族A成员5(HSPA5)、生长分化因子15(GDF15)、肿瘤坏死因子α诱导蛋白3(TNFAIP3)、血红素加氧酶1(HMOX1)、趋化因子(CXCL2)和白细胞介素6(IL6))。我们还预测了coFRG和coIRG的潜在TF-基因网络,以及枢纽基因的潜在基因-药物对。此外,我们发现肠I/R损伤早期免疫细胞发生了改变,并且FRG在小鼠和人类中与免疫细胞密切相关。最后,我们在小鼠样本中验证了枢纽基因。
总之,我们鉴定了铁死亡和免疫相关基因,以预测它们在肠I/R损伤中的相关性。我们还预测了潜在的TF-基因网络和潜在的治疗靶点(HSPA5、GDF15、TNFAIP3、HMOX1、CXCL2和IL6),为进一步研究肠I/R损伤提供线索。